JP2024504328A5 - - Google Patents

Info

Publication number
JP2024504328A5
JP2024504328A5 JP2023543456A JP2023543456A JP2024504328A5 JP 2024504328 A5 JP2024504328 A5 JP 2024504328A5 JP 2023543456 A JP2023543456 A JP 2023543456A JP 2023543456 A JP2023543456 A JP 2023543456A JP 2024504328 A5 JP2024504328 A5 JP 2024504328A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
compound according
groups
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023543456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504328A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/070259 external-priority patent/WO2022159955A1/en
Publication of JP2024504328A publication Critical patent/JP2024504328A/ja
Publication of JP2024504328A5 publication Critical patent/JP2024504328A5/ja
Pending legal-status Critical Current

Links

JP2023543456A 2021-01-21 2022-01-20 肺疾患の治療のための肺胞2型細胞増殖の小分子調節因子 Pending JP2024504328A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163139956P 2021-01-21 2021-01-21
US63/139,956 2021-01-21
PCT/US2022/070259 WO2022159955A1 (en) 2021-01-21 2022-01-20 Small molecule regulators of alveolar type 2 cell proliferation for the treatment of pulmonary diseases

Publications (2)

Publication Number Publication Date
JP2024504328A JP2024504328A (ja) 2024-01-31
JP2024504328A5 true JP2024504328A5 (https=) 2025-01-28

Family

ID=80446393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023543456A Pending JP2024504328A (ja) 2021-01-21 2022-01-20 肺疾患の治療のための肺胞2型細胞増殖の小分子調節因子

Country Status (10)

Country Link
US (1) US20240174675A1 (https=)
EP (1) EP4281439A1 (https=)
JP (1) JP2024504328A (https=)
KR (1) KR20230135625A (https=)
CN (1) CN117177958A (https=)
AU (1) AU2022211069A1 (https=)
CA (1) CA3209219A1 (https=)
IL (1) IL304471A (https=)
MX (1) MX2023008275A (https=)
WO (1) WO2022159955A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3261924A1 (en) * 2022-07-14 2024-01-18 The Scripps Research Institute SMALL MOLECULE REGULATORS OF TYPE 2 ALVEOLAR CELL PROLIFERATION FOR THE TREATMENT OF LUNG DISEASES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5150173A1 (es) * 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
US6995183B2 (en) * 2003-08-01 2006-02-07 Bristol Myers Squibb Company Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
WO2006012441A1 (en) * 2004-07-23 2006-02-02 Susan Marie Royalty Peptidase inhibitors
WO2006090244A1 (en) * 2005-02-22 2006-08-31 Glenmark Pharmaceuticals S.A. New adamantane derivatives as dipeptidyl, peptidase iv inhibitors, processes for their preparation, and pharmaceutical compositions containing them
CN101468988A (zh) * 2007-12-26 2009-07-01 上海恒瑞医药有限公司 哌嗪类衍生物,其制备方法及其在医药上的应用
CN101824036A (zh) * 2009-03-05 2010-09-08 上海恒瑞医药有限公司 四氢咪唑并[1,5-a]吡嗪衍生物的盐,其制备方法及其在医药上的应用
CN101849944A (zh) * 2009-03-31 2010-10-06 江苏恒瑞医药股份有限公司 治疗2型糖尿病的药物组合物
CN103087067A (zh) * 2012-08-02 2013-05-08 盛世泰科生物医药技术(苏州)有限公司 作为二肽基酶抑制剂的化合物及其组合物,以及它们的用途
CN103896923B (zh) * 2012-12-27 2016-03-02 北京莱博赛路森药物科技有限公司 一种降血糖化合物、其制备方法、包含其的药物组合物及其用途
CN107303390A (zh) * 2017-01-22 2017-10-31 复旦大学附属华山医院 Dpp4抑制剂在制备治疗低氧性肺动脉高压药物中的用途

Similar Documents

Publication Publication Date Title
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
CA2815536C (en) Boronates as arginase inhibitors
JP3375961B2 (ja) Hivに対する医薬組成物
JP2014503574A5 (https=)
JP2008510770A5 (https=)
JP2019519598A5 (https=)
JP2014500295A5 (https=)
JP2010530881A5 (https=)
JP2014532716A5 (https=)
JP2008533191A5 (https=)
JP2019529444A5 (https=)
JP2008505157A5 (https=)
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2007535525A (ja) β−カルボリン誘導体を含有する医薬組成物および癌を処置するためのそれらの使用
JP2011509302A5 (https=)
JP2013528659A5 (https=)
KR20220091528A (ko) 4-아미노-이미다조퀴놀린 화합물 및 이의 용도
JP2024504328A5 (https=)
JP7229482B2 (ja) 新規アミド系化合物、並びにそれを用いたPin1阻害剤、炎症性疾患の治療剤及び癌の治療剤
US20060019927A1 (en) Anti-viral uses of borinic acid complexes
JPS58185544A (ja) グアニジン誘導体、その製法及びそれを含有する医薬組成物
JP7039579B2 (ja) 抗癌剤としての4-アニリノ-キノリン化合物
JP2005506324A5 (https=)
JP7760370B2 (ja) 慢性腎臓病の治療又は予防方法
WO2018062954A1 (ko) 사이클로필린 기능 저해제 및 사용방법